EDITOR,-Referral accuracy is an important measure of primary care eVectiveness. It is defined as the proportion of patients referred for a particular condition who are subsequently diagnosed as having that condition (that is, the true positive proportion). Statistically, it estimates the probability that a patient who is referred will have the disease (positive predictive value) and, as with all statistical estimates, the value calculated in any sample will be subject to error, the magnitude of which decreases as the sample size increases. In recent years there has been an increase in the number of publications on the accuracy of referrals by optometrists to ophthalmology clinics. This letter has been prompted by reading some of those concerned with referrals for suspected glaucoma, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] but the issue applies generally to estimates of referral accuracy for any disease condition and, indeed, to all measures of screening eVectiveness that involve calculation of sample proportions, such as sensitivity, specificity, and so on.
The majority of reports of estimated referral accuracy give no indication of the precision (standard error) of the estimates. Although some reported estimates of accuracy are obtained from relatively large samples of referred patients, others are based on samples of 10 patients or less. For example, Dayan et al 4 and Newman et al 6 each report samples of referred patients (sample sizes 11 and 10 respectively) in which there were no positively diagnosed cases. Using these data to estimate referral accuracy in the population gives 99% confidence intervals of 0 to 38% and 0 to 40% respectively. This means that if one sample of 10 patients shows referral accuracy of zero, then the referral accuracy in 99% of samples drawn from the same population would not necessarily be zero but would be expected to lie between 0 and 40%. Newman et al, 6 in subdividing referrals according to the mode of screening, obtain some accuracy estimates from even smaller samples. They report, for example, that two out of five patients referred on the basis of optic disc + visual field assessment gave a positive diagnosis of glaucoma; referral accuracy of 40%. For this sample the 99% confidence interval ranges from 8 to 83%. Awareness of the lack of precision in small sample estimates of referral accuracy is important for correct clinical interpretation. The comparative eVectiveness of diVerent referral strategies or modes of screening should not be judged on the basis of estimates from very small samples. Clinicians should keep in mind the fact that population values for referral accuracy may in some situations be much higher, or indeed lower, than those observed.
It is therefore recommended that authors should routinely report 95% or 99% confidence intervals (CI) for all measures of diagnostic accuracy. When these measures are simple proportions, as is referral accuracy, the general equation for the confidence interval is CI = proportion ± (z × standard error of proportion). In this equation z is the standard normal deviate; z = 1.96 for a two sided 95% CI, or z = 2.58 for a 99% CI. The common simple formula 13 for the standard error s p of a proportion p is where n is the sample size; and the confidence interval is then However a problem with this formula, which is based on a binomial approximation to the normal distribution, is that it can in some circumstances produce confidence limits of less than 0 or greater than 1, when clearly the population proportion must always lie between 0 and 1. This common approximation should therefore be avoided in favour of exact binomial confidence intervals which are available in many statistical software packages. Alternatively, a formula which always gives confidence intervals within the natural limits of 0 and 1, and is also easy to calculate is 14 :
JIM Topical steroid use in the treatment of ocular alkali burns EDITOR,-The article by Davis et al 1 mentions the use of 10% vitamin C eye drops with a pH 5.5-6.5 and the authors specify potassium ascorbate. Preparing for a future emergency I made vitamin C eye drops in my oYce by putting ordinary Norwegian vitamin C tablets in 10 ml saline and found the pH to be 3! I then realised that my vitamin C tablets were ascorbic acid. Therefore, ophthalmologists should be warned: vitamin C could be ascorbic acid or acetate. The ophthalmologist need not prepare homemade vitamin C eye drops in the emergency room. The pharmacist should prepare the eye drops, using either potassium or sodium ascorbate. 1 The latter fact might be the result of failures, which have not been published. Therefore, we would like to communicate own disappointing results. Recently, the intralesional application of OK 432 (Picibanil, Chugai Pharmaceuticals Co, Tokyo, Japan) has been used successfully in the treatment of lymphangiomas in various body sites. 2 Usually, OK 432 is injected in one of the cystic spaces of the tumour, leading to an inflammatory reaction and finally to complete shrinking of the tumour within 4-8 weeks. Encouraged by our own good experiences in the treatment of childhood lymphangiomas of the neck or trunk, we decided to choose this approach in the case of a 22 year old young woman suVering from a histologically proved lymphangioma of the left conjunctiva and anterior orbit. The tumour initially presented in early childhood but did not show significant growth until end of the second decade. One surgical debulking procedure had not led to a satisfactory result. Therefore, we performed two injections of OK 432 within 4 weeks. Though we observed the expected inflammatory reaction and swelling, this was not followed by an involution of the tumour. Three months after OK 432 treatment the prolapse of the conjunctival part of the tumour had even increased. A second and now more successful surgical reduction of the mass was necessary. While we have no explanation for the failure of OK 432 in our case, we believe that, though very successful in other localisations, this treatment might be inappropriate in cases of orbital lymphangioma.
ANDERS OETHER

Reply
EDITOR,-There is a paucity of data on the use of OK 432 in this condition. I have also seen one case with the orbit involved in which this treatment was unsuccessful. Perhaps the Japanese centres will present data from a controlled trial, but from my case and anecdotal reports (including the current one) I have not been impressed. The obvious concern is not to reinvent the wheel regarding minimally eVective therapies. In both orbital haemangiomas and lymphangiomas several treatments were advocated for many years with minimal eVect; hopefully this will not be another one. 
Joachim Kuhlmann Fellowship for Ophthalmologists 2000
The Joachim Kuhlmann AIDS Foundation, Essen, Germany, is sponsoring two fellowships per year for ophthalmologists at a well known institute, who want to train in CMV retinitis and other HIV related ophthalmological diseases. The fellowships are valued at $US5000 each. deadlines for applications are 31 January and 31 July. Detailed applications, including CV and publication list, should be sent to the Joachim Kuhlmann AIDS Founda- 
DR-2000, International Forum on Diabetic Retinopathy
The International Forum on Diabetic Retinopathy will take place on 7-9 September 2000 at the Palazzo Reale, Naples, Italy. 
